3 Reliable Dividend Stocks Yielding Up To 7.4%
Name
Dividend Yield
Dividend Rating
Universal (UVV)
5.68%
★★★★★★
Southside Bancshares (SBSI)
4.64%
★★★★★☆
Huntington Bancshares (HBAN)
3.56%
★★★★★☆
First Interstate BancSystem (FIBK)
6.03%
★★★★★★
Ennis (EBF)
5.41%
★★★★★★
Douglas Dynamics (PLOW)
3.81%
★★★★★☆
Dillard's (DDS)
5.99%
★★★★★★
CompX International (CIX)
4.62%
★★★★★★
Columbia Banking System (COLB)
5.74%
★★★★★★
Citizens & Northern (CZNC)
5.57%
★★★★★☆
Click here to see the full list of 137 stocks from our Top US Dividend Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Spok Holdings, Inc., through its subsidiary Spok, Inc., offers healthcare communication solutions across various regions including the United States, Europe, and Asia, with a market cap of $372.77 million.
Operations: Spok Holdings, Inc. generates revenue of $139.04 million from its Clinical Communication and Collaboration Business segment.
Dividend Yield: 6.9%
Spok Holdings offers a high dividend yield of 6.89%, placing it in the top 25% of US dividend payers, and has maintained stable and growing dividends over the past decade. However, its dividends are not well covered by earnings or free cash flows, with a payout ratio of 159.4% and a cash payout ratio of 98.5%. Recent events include being dropped from the Russell 2000 Dynamic Index, which may impact investor perception.
Navigate through the intricacies of Spok Holdings with our comprehensive dividend report here.
According our valuation report, there's an indication that Spok Holdings' share price might be on the expensive side.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: TriCo Bancshares is a bank holding company for Tri Counties Bank, offering commercial banking services to individual and corporate customers, with a market cap of approximately $1.40 billion.
Operations: TriCo Bancshares generates revenue primarily through its Community Banking segment, which accounted for $389.80 million.
Dividend Yield: 3.1%
TriCo Bancshares provides a reliable dividend yield of 3.08%, though it falls short of the top 25% in the US market. The company has maintained stable and growing dividends over the past decade, supported by a low payout ratio of 38.4%. Recent developments include a quarterly dividend affirmation at $0.33 per share and an auditor change to Baker Tilly US, LLP following the merger with Moss Adams LLP, which does not affect financial reporting stability.
Unlock comprehensive insights into our analysis of TriCo Bancshares stock in this dividend report.
The valuation report we've compiled suggests that TriCo Bancshares' current price could be quite moderate.
Simply Wall St Dividend Rating: ★★★★★☆
Overview: Artisan Partners Asset Management Inc. is a publicly owned investment manager with a market cap of approximately $3.76 billion.
Operations: Artisan Partners Asset Management Inc. generates its revenue primarily from the Investment Management Industry, amounting to $1.12 billion.
Dividend Yield: 7.5%
Artisan Partners Asset Management offers a dividend yield of 7.5%, placing it in the top 25% of US dividend payers, though its dividends have been volatile over the past decade. The company's recent inclusion in multiple Russell indices may enhance visibility among investors. Despite a sustainable payout ratio supported by cash flows and earnings, recent executive changes and insider selling could raise concerns about stability. Revenue and earnings showed modest growth, but future declines are expected.
Click here to discover the nuances of Artisan Partners Asset Management with our detailed analytical dividend report.
Our comprehensive valuation report raises the possibility that Artisan Partners Asset Management is priced lower than what may be justified by its financials.
Get an in-depth perspective on all 137 Top US Dividend Stocks by using our screener here.
Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SPOK TCBK and APAM.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@simplywallst.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
GE HealthCare Technologies Second Quarter 2025 Earnings: EPS Beats Expectations
GE HealthCare Technologies (NASDAQ:GEHC) Second Quarter 2025 Results Key Financial Results Revenue: US$5.01b (up 3.5% from 2Q 2024). Net income: US$486.0m (up 14% from 2Q 2024). Profit margin: 9.7% (in line with 2Q 2024). EPS: US$1.06 (up from US$0.94 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period GE HealthCare Technologies EPS Beats Expectations Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 19%. Looking ahead, revenue is forecast to grow 4.1% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are down 10.0% from a week ago. Valuation Our analysis of these results suggests GE HealthCare Technologies may be undervalued based on 6 important criteria we look at. To explore our complete evaluation click here and get an understanding of what analysts are thinking about the company's future. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Yahoo
iRhythm Technologies Second Quarter 2025 Earnings: Beats Expectations
iRhythm Technologies (NASDAQ:IRTC) Second Quarter 2025 Results Key Financial Results Revenue: US$186.7m (up 26% from 2Q 2024). Net loss: US$14.2m (loss narrowed by 29% from 2Q 2024). US$0.44 loss per share (improved from US$0.65 loss in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period iRhythm Technologies Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 7.3%. Earnings per share (EPS) also surpassed analyst estimates by 16%. Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 8.2% growth forecast for the Medical Equipment industry in the US. Performance of the American Medical Equipment industry. The company's shares are up 23% from a week ago. Risk Analysis It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with iRhythm Technologies, and understanding this should be part of your investment process. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 hours ago
- Yahoo
BOK Financial Second Quarter 2025 Earnings: Beats Expectations
BOK Financial (NASDAQ:BOKF) Second Quarter 2025 Results Key Financial Results Revenue: US$535.3m (down 2.3% from 2Q 2024). Net income: US$138.5m (down 15% from 2Q 2024). Profit margin: 26% (down from 30% in 2Q 2024). The decrease in margin was primarily driven by higher expenses. EPS: US$2.19 (down from US$2.54 in 2Q 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period BOK Financial Revenues and Earnings Beat Expectations Revenue exceeded analyst estimates by 3.4%. Earnings per share (EPS) also surpassed analyst estimates by 11%. Looking ahead, revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Banks industry in the US. Performance of the American Banks industry. The company's shares are down 6.4% from a week ago. Balance Sheet Analysis Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of BOK Financial's balance sheet and an in-depth analysis of the company's financial position. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. 登入存取你的投資組合